Amgen Inc. (AMGN)

$ 288.18
   
  • Change Today:
    $4.64
  • 52 Week High: $339.19
  • 52 Week Low: $258.59
  • Currency: US Dollars
  • Shares Issued: 536.90m
  • Volume: 5,439,225
  • Market Cap: $154,724m
  • RiskGrade: 100

Latest ShareCast News

Horizon Therapeutics tanks as FTC expected to challenge Amgen deal

By Michele Maatouk

Date: Tuesday 16 May 2023

(Sharecast News) - Horizon Therapeutics tumbled in pre-market trade on Tuesday following a report that its $27.8bn takeover by Amgen will be challenged by federal regulators.

Amgen to buy Horizon Therapeutics in $28.3bn deal

By Michele Maatouk

Date: Monday 12 Dec 2022

(Sharecast News) - California-based biopharmaceutical group Amgen has agreed to buy Horizon Therapeutics in a $28.3bn deal.

Japan green lights AstraZeneca asthma drug

By Abigail Townsend

Date: Tuesday 27 Sep 2022

(Sharecast News) - AstraZeneca drug Tezspire has been approved for use with patients with severe asthma in Japan, the blue chip confirmed on Tuesday.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Amgen Inc. Market Data

Currency US Dollars
Share Price $ 288.18
Change Today $ 4.64
% Change 1.64 %
52 Week High $339.19
52 Week Low $258.59
Volume 5,439,225
Shares Issued 536.90m
Market Cap $154,724m
RiskGrade 100

What The Brokers Say

Strong Buy 6
Buy 6
Neutral 15
Sell 2
Strong Sell 1
Total 30
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 30-May-2025

Time Volume / Share Price
16:00 200 @ $287.80
16:00 147 @ $287.81
16:00 1,638 @ $287.81
16:00 2,500 @ $287.81
16:00 200 @ $287.82

Top of Page